ORIC (ORIC Pharmaceuticals) Other Income (Expense): $15.79 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORIC ORIC Pharmaceuticals Inc ORIC
34 GF Score
Price $12.84
! 4 Warning Signs
View Full Analysis

What is ORIC Pharmaceuticals Other Income (Expense)?

ORIC Pharmaceuticals ORIC +1.02% 34 Other Income (Expense) is $15.79 Mil as of Jun. 2026. GuruFocus rates ORIC with a GF Score™ of 34/100. The stock has 4 warning signs investors should review.

ORIC Pharmaceuticals's other income expense for the ORIC Pharmaceuticals's pretax income for the three months ended in Jun. 2026 was $3.80 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2026 was $15.79 Mil.

ORIC Pharmaceuticals  (NAS:ORIC) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

ORIC Pharmaceuticals Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for ORIC Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ORIC Pharmaceuticals Other Income (Expense) Chart

ORIC Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Income (Expense)
Get a 7-Day Free Trial 0.01 -5.00 10.08 15.05 13.54

ORIC Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 4.08 4.05 3.85 3.80
ORIC
34GF Score
ORIC Pharmaceuticals Inc ORIC
Other Income (Expense) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ORIC Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of $15.79 Mil mean?
ORIC Pharmaceuticals (ORIC) has a Other Income (Expense) of $15.79 Mil as of Jun. 2026. Other income and expenses that a company records on the income statement. View historical data on ORIC Pharmaceuticals and its competitors.
Is ORIC Pharmaceuticals' Other Income (Expense) too high?
ORIC Pharmaceuticals' current Other Income (Expense) is $15.79 Mil. Overall, ORIC Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does ORIC Pharmaceuticals' Other Income (Expense) compare to ANRO and DRTS?
ORIC Pharmaceuticals' Other Income (Expense) of $15.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Biotechnology company?
A good Other Income (Expense) depends on the Biotechnology industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on ORIC Pharmaceuticals and its competitors. ORIC Pharmaceuticals's current Other Income (Expense) is $15.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ORIC Pharmaceuticals stock overvalued right now?
ORIC Pharmaceuticals (ORIC) has a current Other Income (Expense) of $15.79 Mil. The current Other Income (Expense) is $15.79 Mil. ORIC Pharmaceuticals' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For ORIC Pharmaceuticals (ORIC), the current Other Income (Expense) is $15.79 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ORIC Pharmaceuticals Business Description

Other Exchanges 4TZ:Germany
Address 240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
34GF Score

Get the complete analysis for ORIC

Other Income (Expense) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.84
Price